Peptides with Neurotrophic Properties: Promising Therapeutics for Amyotrophic Lateral Sclerosis and Alzheimer’s Disease.
Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) are two of the more common neurodegenerative diseases, with nearly seven million people in the US living with the conditions in 2023. While AD is more prevalent than ALS, they are both characterized by the progressive loss of specific neurons and glial cells in the central nervous…
